Steroid-Antiviral Treatment in Rehabilitation of Facial Palsy

Status Completed

Clinical Trial Summary

The purpose of this study is to assess the efficacy of antiviral medicine (acyclovir) in recovery of complete facial Palsy. Fifty patients (Males and females) with acute Facial Palsy within the first 3 days of onset with age ranged from 15-60 years old. Each patient was submitted to the following clinical evaluation using House and Brackmann 6 facial function scoring system and Synnybrook grading system. Neurophysiological assessment of facial nerve and muscles was done before and after the end of treatment, then after the end of first and second month of treatment. EMG was done for facial muscles of both sides beside measuring facial nerve excitability to determine the excitation threshold by recording the minimum electrical stimulus required to produce visible muscle contraction. A difference greater than 3.5 mA between the affected and unaffected side is considered significant in terms of poor prognosis. Nerve conduction study of facial nerves of both sides using concentric needle electrode. Trigeminal Blink reflex for both sides of the face. Facial functional recovery was defined as "good" or "complete" using the same criteria used in the 2001 practice guideline. An outcome of grade I or II was considered a good recovery using the House and Brackmann 6 facial function scoring system

Clinical Trial Description

The purpose of this study is to assess the efficacy of antiviral medicine (acyclovir) in recovery of complete facial Palsy. Fifty patients (Males and females) with acute Facial Palsy within the first 3 days of onset with age ranged from 15-60 years old. Each patient was submitted to the following clinical evaluation using House and Brackmann 6 facial function scoring system and Synnybrook grading system. Neurophysiological assessment of facial nerve and muscle was done before and after the end of treatment, then after the end of first and second month of treatment. EMG was done for facial muscles of both sides beside measuring facial nerve excitability to determine the excitation threshold by recording the minimum electrical stimulus required to produce visible muscle contraction. A difference greater than 3.5 mA between the affected and unaffected side is considered significant in terms of poor prognosis. Nerve conduction study of facial nerves of both sides using concentric needle electrode. Trigeminal Blink reflex for both sides of the face. Facial functional recovery was defined as "good" or "complete" using the same criteria used in the 2001 practice guideline. An outcome of grade I or II was considered a good recovery using the House and Brackmann 6 facial function scoring system ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02328079
Study type	Interventional
Source	Assiut University
Contact
Status	Completed
Phase	N/A
Start date	April 2013
Completion date	November 2014

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05581680` - Multimodal Quantified Analysis of Facial Movements: Comparison Between Pathological and Control Subjects	N/A
Completed	`NCT06334796` - Artificial Intelligence-powered Virtual Assistant for Emergency Triage in Neurology	Early Phase 1
Completed	`NCT04993417` - Comparison of Motor Imagery Technique and Mime Therapy on Facial Expressions in Facial Palsy Patients	N/A
Completed	`NCT02486393` - Complications in Parotid Surgery	N/A
Completed	`NCT05094245` - Stellate Gnaglion Block in Refractory Bell's Palsy	N/A
Recruiting	`NCT04886245` - Eye-Tracking FP "A Pilot Study of the Quantitative Evaluation of the Attention Paid to Faces With Facial Palsy by the Eye-tracking Technology.	N/A
Recruiting	`NCT03781700` - Evaluation of Cortisone Treatment in Children With Acute Facial Nerve Palsy	Phase 4
Completed	`NCT03006783` - Assessment of the Cross-face Nerve Graft in the Treatment of Facial Paralysis	N/A
Completed	`NCT00438087` - Corticosteroids in Prevention of Facial Palsy After Cranial Base Surgery	Phase 3
Recruiting	`NCT05981651` - Development and Application of a Dynamic Three-dimensional Quantitative Facial Measurement Device
Recruiting	`NCT04074018` - Impacts of Two Rehabilitation Programs on Chronic Peripheral Facial Paresis	N/A
Recruiting	`NCT04237961` - Ancillary Procedures in Patients of Refractory Facial Palsy Patients Selection and Evaluation of the Outcomes	N/A
Recruiting	`NCT05191719` - Neurotomy to Treat Synkinesis Following Peripheral Facial Palsy	N/A
Recruiting	`NCT03059420` - Genetic Studies of Strabismus, Congenital Cranial Dysinnervation Disorders (CCDDs), and Their Associated Anomalies
Completed	`NCT03943953` - Self-guided Psychosocial Intervention for Facial Palsy	N/A
Completed	`NCT03619720` - Emotional Perception and Production in Facial Palsy: Respiratory, Vocal and Facial Markers.	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.